e-Library of Evidence for Nutrition Actions (eLENA)

Calcium supplementation during pregnancy to reduce the risk of pre-eclampsia

Hypertensive disorders* such as pre-eclampsia and eclampsia are among the main causes of maternal deaths and preterm births, especially in low-income countries. Preterm births are the leading cause of early neonatal deaths and infant mortality, and survivors are at higher risk of respiratory disease and long-term neurological morbidity.

Normally, during early pregnancy, blood pressure falls and then slowly rises until the end of pregnancy. However, obesity, diabetes, twin or teenage pregnancies and low calcium consumption alter this equilibrium and increase the risk of developing pre-eclampsia. Calcium supplementation improves calcium intake and consequently reduces the risk of hypertensive disorders during pregnancy.

*disorders in which blood pressure is elevated

WHO recommendations

In populations with low dietary calcium intake, daily calcium supplementation (1.5 g - 2.0 g oral elemental calcium) is recommended for pregnant women to reduce the risk of pre-eclampsia.*

* This recommendation is consistent with the recommendations in ‘WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia’ (2011) and supercedes the previous recommendation found in the WHO guideline ‘Calcium supplementation in pregnant women’ (2013).

*************

Additional information for this recommendation can be found in the guidance summary and in the guideline, under 'WHO documents' below.

WHO documents

WHO documents


GRC-approved guidelines
Evidence

Evidence


Systematic reviews used to develop the guidelines
Related Cochrane reviews
Other related systematic reviews
Clinical trials

Last update:

15 June 2017 11:05 CEST

Category 1 intervention

Guidelines have been recently approved by the WHO Guidelines Review Committee

Essential Nutrition Actions

This intervention is an Essential Nutrition Action targeting the first 1000 days of life.

Related links